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Abstract
Background and objectives: Nanoparticles (f{Ps) have been created with a ,.* urd
emerging characteristics with the development of nanotechnology and material engineering,
and these materials have also been increasingly used despite their potential toxic effects are
unknown in many cases. The nanoscale of molybdenum trioxide has athacted a lot of
affention today. These nanoparticles are mainly used in the industry, glass and as cracking
catalysts, hydrogenation catalysts and the production of refractory alloys. In spite of their
wide range of uses, these materiais may have potentially harmful effects, as the small size of
the nanoparticles allows them to overcome the body's defenses. Regarding the application of
nanotechnology and the possible effects of these substances on the growth, proliferation and
survival of cells and organisms, this study was to investigate the toxicity of molybdenum
trioxide nanoparticles in blood and body tissues of rats.
Methods: 30 wistar rats, with a weighing average 200 + 10 g were used. Rats were divided
into three groups: control and intervention group with high and low dose. Molybdenum nano
trioxide (5 and 10 mg / kg body weight) was injected to the rats for 28 days. At the next stage,
the animals were sacrificed and blood samples and their organs were collected to measure the
molybdenum content. Ultimately, molybdenum concentration was measured by flame atomic
absorption.
Results: The results of this study showed that 10 mg nanoparticles significantly has reduced
hematocrit (P <0.01), hemoglobin (P <0.01), red and white blood cells @ <0.01) compared to
the other two groups. Also, with 5 and 10 mg nanoparticles, the number'of platelets
decreased, but this decrease was not statistically significant (P : .122). Part of the results
showed that the amount of molybdenum trioxide nanoparticles in the heart, liver and kidneys
of rate who were fed with 10 mg / kg was significantly higher than the other two groups (P
<0.01).
Conclusion: The results of this study showed that nanoparticles of molybdenum at high
concentrations (10 mg / kg) had a more toxic effect on blood and serum parameters compared
to low concentrations. The results of this study confirmed the toxicity of molybdenum
Trioxide nanoparticles and it is likely that the administration of molybdenum tioxid
nanoparticles at two different concentrations due to an increase in the leakage of alanine
aminotransferase, alkaline phosphatase and aspartate aminotransferase enzymes from liver
cells and their elevated serum levels leads to poisoning the rate through causing impaired liver
function and damage to liver cells and liver damage.
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